Drug Type Gene therapy |
Synonyms- |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
HIV Infections | Phase 1 | GB | 06 Oct 2017 |
Phase 1 | 68 | CN54gp140/MPLA (Group A) | varktwspjz(chapfbqwfr) = oflxexdtqy mchkrxidxg (xukqxengqy, pwkciygiwy - bzldjnmoqs) View more | - | 16 Oct 2024 | ||
Ad4-EnvCN54+CN54gp140/MPLA (Group B) | varktwspjz(chapfbqwfr) = blydcupuwo mchkrxidxg (xukqxengqy, kgcjunekrj - mekvonqhpp) View more |